Accessing Cell and Gene Therapy Research Expertise in the UK

Formed through partnerships between leading NHS organisations and universities, National Institute for Health Research Biomedical Research Centres (BRCs) conduct translational research to transform scientific breakthroughs into life-saving treatments for patients.

Following on from last year's successful NIHR BRC Showcase, MedCity, the NIHR, and the Cell and Gene Therapy Catapult are hosting a second event focussed on Cell and Gene Therapy.

Join us at Kings Place, London on Thursday 15 March to hear from and network with renowned BRCs from across Cambridge, London and Oxford, find out about their successful projects and better understand the opportunities available to work collaboratively with the BRCs.

Event Agenda:

9.00 Arrival, Registration and Coffee

9.15 - 9:30 Introduction and Welcome (Professor Simon Howell, MedCity Catalyst Fund Grant Holder and Director of Academic Estates Strategy for Health Campuses, King's College London)

9:30 - 9:50 Overview of the NIHR Biomedical Research Centres (TBC)

9:50 - 10:10 The role of the Cell and Gene Therapy Catapult in accelerating commercialisation of research (Matthew Durdy, Chief Business Officer, Cell and Gene Therapy Catapult)

10:15 - 11:15 Panel Discussion: Perspectives in transitioning from the development of cell and gene therapies to commercialisation

Chair: Sarah Haywood, CEO, MedCity

11.15 Break

11.45 – 15.00 Biomedical Research Centre Exhibition

Take this opportunity to network with the BRCs and find out about their capabilities along the therapy development pathway; including cell and gene therapy portfolio, clinical delivery and commercialisation. It includes:

13.00 – 16.00 Masterclasses

1. Accelerating translation of the academic pipeline

The UCL Translational Research Office and UCL Business will outline the ways in which they support translation and commercialisation of cell and gene therapy including successful case studies.

2. Oncolytic viruses as a new gene therapy

By Professor Alan Melcher, Professor of Translational Immunology and Honorary Consultant Oncologist at The Royal Marsden Hospital.

3. From idea to adoption - the NIHR Innovation Pathway

The NIHR's Clare Woods, Business Development Manager, and Ginette Hoare, Industry Operations Manager, will explore the many ways that the NIHR is supporting industry to deliver early phase translational research in the NHS, through research funding, access to expertise and study support.

4. Cell and Gene Therapy Catapult masterclass (TBC)

15:00 – 17.00 1:1s and networking

Register here

Discover who we are